RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 16, 16:00
RVL Pharmaceuticals Cash from Operations (TTM): -44.41M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -44.41M |
| March 31, 2023 | -30.35M |
| December 31, 2022 | -37.81M |
| September 30, 2022 | -45.77M |
| June 30, 2022 | -51.60M |
| March 31, 2022 | -56.52M |
| December 31, 2021 | -54.73M |
| September 30, 2021 | -38.59M |
| June 30, 2021 | -13.12M |
| March 31, 2021 | 6.168M |
| Date | Value |
|---|---|
| December 31, 2020 | 17.59M |
| September 30, 2020 | 26.52M |
| June 30, 2020 | 54.03M |
| March 31, 2020 | 39.63M |
| December 31, 2019 | 33.57M |
| September 30, 2019 | 63.28M |
| June 30, 2019 | 33.45M |
| March 31, 2019 | 24.33M |
| December 31, 2018 | 37.56M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-56.52M
Minimum
Mar 2022
63.28M
Maximum
Sep 2019
-5.805M
Average
-13.12M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.516M |
| Palatin Technologies Inc | -33.74M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -7.291M |